Chemotherapy News and Research

Latest Chemotherapy News and Research

Hematopoietic stem cell transplant improves survival for multiple myeloma patients

Researchers at UC Davis have confirmed that autologous hematopoietic stem cell transplant improves survival for people suffering from multiple myeloma, yet many potentially eligible patients never undergo the procedure.

13 Jun 2018

New discovery could have significant implications in brain aging and cancers

Scientists at the University of Sheffield have discovered what keeps the perfect balance of breaks and repairs in our DNA - something which could help improve the success of chemotherapy and combat neurodegeneration associated with aging.

13 Jun 2018

Scientists discover first genetic marker for bone tumor

The first genetic marker for the bone tumor, osteoblastoma, has been discovered by scientists at the Wellcome Sanger Institute and their collaborators.

12 Jun 2018

Researchers discover new method to predict chance of cancer treatment success

Doctors are increasingly fighting cancer by stimulating patients' immune systems. SNSF-supported researchers have now discovered a method for predicting the likelihood of treatment success.

12 Jun 2018

Scientists pinpoint potential treatment target for pediatric liver cancer

A protein in the cell nucleus already targeted therapeutically for several types of cancer has now been linked to an aggressive form of pediatric liver cancer called hepatoblastoma (HBL), according to a study published in the Nature journal Communications Biology.

11 Jun 2018

Novel computer models for individualization of HIV therapy in countries with limited healthcare resources

New predictive computer models designed to optimize HIV therapy in countries with limited healthcare resources are published online this week in the Journal of Antimicrobial Chemotherapy.

11 Jun 2018

Biotheranostics presents key data for CancerTYPE ID and Breast Cancer Index at ASCO 2018

Biotheranostics, Inc. announces new data from studies for both of its proprietary molecular diagnostic tests, CancerTYPE ID and Breast Cancer Index to be presented on Saturday, June 2nd and Monday, June 4th at the annual meeting of the American Society of Clinical Oncology in Chicago.

8 Jun 2018

Colorado researchers suggest new combination therapy for advanced head and neck cancer

The five-year survival rate for locally-advanced head and neck cancer is only 46 percent, even with treatments including surgery, radiation, chemotherapy and/or genetically targeted treatments such as cetuximab.

7 Jun 2018

Understanding cancer heterogeneity may help avoid harmful effects of chemotherapy

"Understanding cancer heterogeneity could further reduce chemo use," says cancer research expert Antonio Giordano, MD, PhD, Director of the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University. "Further study of cases that can successfully be treated with hormone- and immunotherapy, and how to identify them, will unlock this potential."

7 Jun 2018

International 'A' team unveils new glioblastoma atlas

It takes an "A" team to make headway against glioblastoma, a highly aggressive type of brain cancer. Glioblastoma is the most common type of malignant brain tumor in adults. In addition to the caliber of the researchers involved, in this case "A" also stands for atlas.

6 Jun 2018

Gas embolotherapy holds great potential for treating cancer

Embolization -- the use of various techniques to cut off the blood vessels that feed tissue growth -- has gained traction over the past few decades to treat cancerous tumors.

6 Jun 2018

Zebrafish may hold answers to how tumors develop in childhood muscle cancer

A popular aquarium fish may hold answers to how tumors form in a childhood cancer.

6 Jun 2018

World’s most advanced video camera to develop cures for lethal forms of cancer

The Rosalind Franklin Institute today launched an ambitious new project to build the world’s most advanced real-time high-speed video camera, the key to understanding new techniques that use light and sound to treat some of the most lethal forms of cancer.

6 Jun 2018

Researchers explore targeted second-line treatment for colorectal cancer

Targeted therapy with anti-VEGF and anti-EGFR antibodies both improve outcomes when added to chemotherapy in the treatment of colorectal cancer. However, some previous studies suggested the combination of the two antibodies may have a negative interaction.

5 Jun 2018

Study identifies four tumor survival strategies in childhood cancer

Researchers have identified four main trajectories for the development of childhood cancer, two of which have been linked to disease relapse.

5 Jun 2018

Study shows four survival strategies of tumor cells in childhood cancer

Cancer cells in children tend to develop by following four main trajectories - and two of them are linked to relapse of the disease, research led by Lund University in Sweden shows.

5 Jun 2018

Chemotherapy may provide no benefit for breast cancer in some cases

In a new study a team of researchers have found that chemotherapy can be completely skipped in early stage breast cancer patients provided certain genetic tests of the tumours are made to assess the risk.

5 Jun 2018

Breast cancer treated successfully with immune therapy

According to researchers from the US, early breast cancers can be successfully treated with a new form of immune therapy instead of traditional chemotherapy. The details of the treatment and the case is published in the journal Nature Medicine.

5 Jun 2018

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

The U.S. Food and Drug Administration today approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta (pegfilgrastim) to decrease the chance of infection as suggested by febrile neutropenia (fever, often with other signs of infection, associated with an abnormally low number of infection-fighting white blood cells), in patients with non-myeloid (non-bone marrow) cancer who are receiving myelosuppressive chemotherapy that has a clinically significant incidence of febrile neutropenia.

4 Jun 2018

Free-floating DNA analysis test may help detect early-stage lung cancer

A test that analyzes free-floating DNA in the blood may be able to detect early-stage lung cancer, a preliminary report from the ongoing Circulating Cell-Free Genome Atlas study suggests.

4 Jun 2018